Natrium Chloratum Teva-„pm” (Sodium Chloride)

After intravenous administration, sodium chloride dissociates into sodium and chloride ions. Sodium increases extracellular osmolarity, drawing water into the vascular space and expanding plasma volume. Chloride participates in maintaining acid‑base balance, together helping to restore normal fluid and electrolyte homeostasis.

The specific dose and infusion rate of Natrium Chloratum Teva-„pm are determined by the prescribing clinician based on the patient’s clinical condition, weight, serum electrolyte levels, and overall fluid requirements. Dosing is individualized and should follow the prescriber’s orders.

Safety data for Natrium Chloratum Teva-„pm in pregnancy and lactation are limited. Clinicians should evaluate the potential benefits against any possible risks and consider alternative therapies when appropriate. Pregnant or nursing patients should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Natrium Chloratum provides a simple isotonic saline solution (0.9% NaCl) that primarily restores sodium and fluid volume. Compared with balanced solutions such as Lactated Ringer’s, it lacks additional electrolytes like potassium, calcium, and lactate, making it suitable when only sodium chloride replacement is needed or when other electrolytes must be avoided.

Store Natrium Chloratum Teva-„pm at controlled room temperature, typically below 25 °C. Keep the vial in its original packaging, protect it from direct light and moisture, and avoid freezing. Inspect the solution for particulate matter or discoloration before use.

The product is administered intravenously. It can be given as a direct infusion or added to compatible IV fluids, following aseptic technique. The infusion rate should be adjusted according to the patient’s clinical status, with continuous monitoring of vital signs and electrolyte levels.

Serious risks include severe hypernatremia, fluid overload leading to pulmonary edema, and rare allergic reactions such as anaphylaxis. Monitoring serum sodium, fluid balance, and patient response during infusion helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride, severe hypernatremia, uncontrolled fluid overload, or advanced renal failure should avoid this product unless closely supervised by a physician. Caution is also advised in individuals with congestive heart failure or severe hypertension.